Viewing Study NCT06408649



Ignite Creation Date: 2024-05-11 @ 8:31 AM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06408649
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-20
First Post: 2024-05-07

Brief Title: Post-market Clinical Follow-up Study of Alcon TOTAL30 Contact Lenses Lehfilcon A
Sponsor: Alcon Research
Organization: Alcon Research

Study Overview

Official Title: Post-market Clinical Follow-up Study of Alcon TOTAL30 Spherical Contact Lenses Lehfilcon A and TOTAL30 for Astigmatism Contact Lenses Lehfilcon A
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this Post-Market Clinical Follow-Up PMCF study is to continuously assess the visual performance and safety of TOTAL30 Sphere and TOTAL30 for Astigmatism contact lenses in a real-world setting across a broad variety of patients through routine clinical practices
Detailed Description: The Baseline visit is defined as the first office visit where an eye care professional provided an in-person office biomicroscopy exam to the subject before or during which a TOTAL30 sphere or toric contact lens prescription was released Baseline visit data will be collected retrospectively chart review

The Year 1 visit is defined as the visit that occurs 1 year -26 months since the Baseline visit during which period the subject is wearing test lenses of the same design in both eyes and a contact lens examination is performed Year 1 data will be collected either retrospectively or prospectively eye exam

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None